ADAXION THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 02 Sept 2025)
What this means for you
Not registered yet, but its 19 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98860792
- Mark type
- Stylized text
- Filed
- 19 Nov 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents for the treatment and prevention of autoimmune, inflammatory, musculoskeletal, oncological, ophthalmic, and metabolic diseases, and cancer
- Class 042 — Scientific and technological services: Research and development services in the field of pharmaceuticals
Owner
- ADAXION THERAPEUTICS, INC., SAN DIEGO, CA, US
- ADAXION THERAPEUTICS, INC., SAN DIEGO, CA, US
- Nighthawk Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Sept 2025 — SOU EXTENSION 1 GRANTED
- 02 Sept 2025 — SOU EXTENSION 1 FILED
- 02 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 14 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 May 2025 — EXAMINERS AMENDMENT E-MAILED
- 14 May 2025 — EXAMINERS AMENDMENT -WRITTEN
- 13 May 2025 — ASSIGNED TO EXAMINER
- 26 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED